featured
Efficacy and Safety of an Aflibercept Biosimilar vs Originator Product in Patients With Neovascular AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology Retina
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration
Ophthalmol Retina 2024 Aug 01;8(8)744-753, R Karkhaneh, H Faghihi, H Riazi-Esfahani, M Abrishami, F Bazvand, N Ebrahimiadib, M Johari, M Akhlaghi, N Shoeibi, MH Norouzzadeh, MR Ansari Astaneh, H Khojasteh, M Imani Fooladi, A Khodabande, F Ghassemi, E Khalili Pour, M Zarei, A Mirshahi, F Fazel, H Ashraf, SM Hosseini, M Dourandeesh, M Feghhi, Y Alizadeh, H Behboudi, P Azadi, A Sabzvari, H Kafi, K Ghasemi FalavarjaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.